Rectal artesunate stakeholders' meeting report

25 May 2016

A summary of key issues relating to adoption and implementation of rectal artesunate and recommended actions to speed up access to this life saving medicine

On 19 February 2016, stakeholders from 13 organizations* spanning the field of malaria prevention and control, seven malaria-endemic countries in Africa (Democratic Republic of Congo, Burkina Faso, Malawi, Central African Republic, Kenya, Uganda and Zambia) and the WHO came together to discuss experiences, challenges and overcoming obstacles relating to the implementation of RAS as a pre-referral intervention for the management of severe malaria in children. The meeting was co-convened in Nairobi, Kenya by Medicines for Malaria Venture (MMV), the US President’s Malaria Initiative (PMI), UNICEF and Médecins Sans Frontières (MSF).
 
This report of the RAS Stakeholder Meeting summarises the key issues relating to the adoption and implementation of RAS in malaria-affected regions and outlines recommended actions to speed up access to this life saving medicine.
 

* CHAI, CDC, IFRC, Malaria Consortium, MMV, MSF, PFSCM i+ solutions, PSI, Save the Children, UNICEF, UNITAID, USAID, US-PMI.